European Society of Cardiology 2014: St Jude's FFR technology has impact on patients suffering from NSTEMI
A new study from St. Jude Medical (St. Paul, Minnesota) is breathing new life into the company's Fractional Flow Reserve (FFR) technology. The company reported results from a new multi-center clinical trial that has found that using its PressureWire FFR technology changed the course of treatment for more than one fifth of patients suffering non-ST segment elevation myocardial infarction (NSTEMI) heart attacks. The data also demonstrated that FFR-guided PCI is safe and tended to reduce procedure-related myocardial infarctions in NSTEMI patients over angiography alone.
Apogee in Asia: Has China peaked?
Mainland China has been the med tech world s hot spot for some time now thanks to a population exceeding a billion and a growing middle class. Some of that affection has shifted to India, perhaps not a bad idea even if you discount some recent news.
Protectionist policy being pursued: China to promote domestic devices among its top hospital facilities
Chinese authorities reported on Aug. 16 that they would establish a methodology to promote Chinese medical devices among top tier hospitals nationwide. The government made the announcement at a joint meeting of the National Health and Family Planning Commission (NHFPC) and the Ministry of Industry and Information Technology (MIIT).